{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:56:11Z","timestamp":1788461771790,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","award":["2019 FGR 0095"],"award-info":[{"award-number":["2019 FGR 0095"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["T942"],"award-info":[{"award-number":["T942"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.bcp.2022.115385","type":"journal-article","created":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T20:05:40Z","timestamp":1671221140000},"page":"115385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Highly potent and selective 5-lipoxygenase inhibition by new, simple heteroaryl-substituted catechols for treatment of inflammation"],"prefix":"10.1016","volume":"208","author":[{"given":"Verena","family":"Krauth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Pace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Temml","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Preziosa Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haroon","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonietta","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Filosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Werz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.bcp.2022.115385_b0005","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1016\/S0021-9258(19)69410-X","article-title":"Evidence for inhibition of leukotriene A4 synthesis by 5,8,11,14-eicosatetraynoic acid in guinea pig polymorphonuclear leukocytes","volume":"256","author":"Bokoch","year":"1981","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.bcp.2022.115385_b0010","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/s41589-020-0544-7","article-title":"Structural and mechanistic insights into 5-lipoxygenase inhibition by natural products","volume":"16","author":"Gilbert","year":"2020","journal-title":"Nat. Chem. Biol."},{"issue":"9","key":"10.1016\/j.bcp.2022.115385_b0015","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/0006-2952(91)90501-U","article-title":"Inhibition of mammalian 5-lipoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives Relationship to antioxidant activity and to iron ion-reducing ability","volume":"42","author":"Laughton","year":"1991","journal-title":"Biochem. Pharmacol."},{"issue":"13","key":"10.1016\/j.bcp.2022.115385_b0020","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1055\/s-2007-990242","article-title":"Inhibition of 5-lipoxygenase product synthesis by natural compounds of plant origin","volume":"73","author":"Werz","year":"2007","journal-title":"Planta Med."},{"issue":"7","key":"10.1016\/j.bcp.2022.115385_b0025","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1172\/JCI97945","article-title":"Leukotriene biosynthetic enzymes as therapeutic targets","volume":"128","author":"Haeggstr\u00f6m","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.bcp.2022.115385_b0030","first-page":"331","article-title":"5-Lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease","volume":"1851","author":"Radmark","year":"2015","journal-title":"BBA"},{"issue":"6","key":"10.1016\/j.bcp.2022.115385_b0035","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.bbalip.2018.07.002","article-title":"Selectivity of phospholipid hydrolysis by phospholipase A2 enzymes in activated cells leading to polyunsaturated fatty acid mobilization","volume":"1864","author":"Astudillo","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.bcp.2022.115385_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114759","article-title":"Untangling the web of 5-lipoxygenase-derived products from a molecular and structural perspective: The battle between pro- and anti-inflammatory lipid mediators","volume":"193","author":"Gilbert","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2022.115385_b0045","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0968-0896(00)00258-3","article-title":"New bis-catechols 5-lipoxygenase inhibitors","volume":"9","author":"Dupont","year":"2001","journal-title":"Bioorg. Med. Chem."},{"issue":"6","key":"10.1016\/j.bcp.2022.115385_b0050","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.plefa.2003.11.006","article-title":"Spice phenolics inhibit human PMNL 5-lipoxygenase","volume":"70","author":"Prasad","year":"2004","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"issue":"2","key":"10.1016\/j.bcp.2022.115385_b0055","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0162-0134(02)00511-1","article-title":"Iron and copper chelation by flavonoids: an electrospray mass spectrometry study","volume":"92","author":"Fernandez","year":"2002","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.bcp.2022.115385_b0060","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.bcp.2016.04.019","article-title":"The 5-lipoxygenase inhibitor RF-22c potently suppresses leukotriene biosynthesis in cellulo and blocks bronchoconstriction and inflammation in vivo","volume":"112","author":"Schaible","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2022.115385_b0065","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.ejmech.2016.10.046","article-title":"Optimization of benzoquinone and hydroquinone derivatives as potent inhibitors of human 5-lipoxygenase","volume":"127","author":"Peduto","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2022.115385_b0070","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejmech.2017.10.020","article-title":"Recent advances in the search for novel 5-lipoxygenase inhibitors for the treatment of asthma","volume":"153","author":"Bruno","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2022.115385_b0075","doi-asserted-by":"crossref","unstructured":"F.K. Bruno, V.; Fratianni, F.; Spaziano, G.; Nazzaro, F.; Roviezzo, F.; Xiao, J.; Kahn, H.; Romano, M.P.; D\u2019Agostino, B.; Werz, O.; Filosa, R., Design and Synthesis of Functionalized 4-Aryl-Catechol Derivatives as New Anti-inflammatory Agents with in vivo Efficacy Eur J Med Chem, in press, DOI:10.1016\/j.ejmech.2022.114788 (2022).","DOI":"10.2139\/ssrn.4111366"},{"issue":"8","key":"10.1016\/j.bcp.2022.115385_b0080","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1172\/JCI92885","article-title":"Androgen-mediated sex bias impairs efficiency of leukotriene biosynthesis inhibitors in males","volume":"127","author":"Pace","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bcp.2022.115385_b0085","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.chembiol.2018.10.010","article-title":"Melleolides from Honey Mushroom Inhibit 5-Lipoxygenase via Cys159","volume":"26","author":"K\u00f6nig","year":"2019","journal-title":"Cell Chem. Biol."},{"issue":"29","key":"10.1016\/j.bcp.2022.115385_b0090","doi-asserted-by":"crossref","first-page":"26913","DOI":"10.1074\/jbc.M500068200","article-title":"1-Oleoyl-2-acetylglycerol stimulates 5-lipoxygenase activity via a putative (phospho)lipid binding site within the N-terminal C2-like domain","volume":"280","author":"H\u00f6rnig","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.bcp.2022.115385_b0095","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1096\/fj.02-0815fje","article-title":"Phosphorylation- and stimulus-dependent inhibition of cellular 5-lipoxygenase activity by nonredox-type inhibitors","volume":"17","author":"Fischer","year":"2003","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.bcp.2022.115385_b0100","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12951-020-00620-7","article-title":"Encapsulation of the dual FLAP\/mPEGS-1 inhibitor BRP-187 into acetalated dextran and PLGA nanoparticles improves its cellular bioactivity","volume":"18","author":"Shkodra-Pula","year":"2020","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.bcp.2022.115385_b0105","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bcp.2017.02.004","article-title":"Selective upregulation of TNF\u03b1 expression in classically-activated human monocyte-derived macrophages (M1) through pharmacological interference with V-ATPase","volume":"130","author":"Thomas","year":"2017","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2022.115385_b0110","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1124\/jpet.108.139444","article-title":"Licofelone suppresses prostaglandin E2 formation by interference with the inducible microsomal prostaglandin E2 synthase-1","volume":"326","author":"Koeberle","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"12","key":"10.1016\/j.bcp.2022.115385_b0115","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0006-2952(02)01387-4","article-title":"Hyperforin is a dual inhibitor of cyclooxygenase-1 and 5-lipoxygenase","volume":"64","author":"Albert","year":"2002","journal-title":"Biochem. Pharmacol."},{"issue":"11","key":"10.1016\/j.bcp.2022.115385_b0120","first-page":"1605","article-title":"Development of smart cell-free and cell-based assay systems for investigation of leukotriene C(4) synthase activity and evaluation of inhibitors","volume":"1861","author":"Liening","year":"2016","journal-title":"BBA"},{"issue":"6","key":"10.1016\/j.bcp.2022.115385_b0125","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1016\/S0021-9258(19)83641-4","article-title":"A new generation of Ca2+ indicators with greatly improved fluorescence properties","volume":"260","author":"Grynkiewicz","year":"1985","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2022.115385_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105556","article-title":"Anti-inflammatory celastrol promotes a switch from leukotriene biosynthesis to formation of specialized pro-resolving lipid mediators","volume":"167","author":"Pace","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2022.115385_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2014.05.011","article-title":"In vivo sex differences in leukotriene biosynthesis in zymosan-induced peritonitis","volume":"87","author":"Rossi","year":"2014","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.bcp.2022.115385_b0140","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1742-1241.2007.01320.x","article-title":"Zileuton: clinical implications of 5-Lipoxygenase inhibition in severe airway disease","volume":"61","author":"Berger","year":"2007","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.bcp.2022.115385_b0145","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejmech.2015.02.042","article-title":"Novel series of benzoquinones with high potency against 5-lipoxygenase in human polymorphonuclear leukocytes","volume":"94","author":"Filosa","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"2 Pt 2","key":"10.1016\/j.bcp.2022.115385_b0150","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1164\/ajrccm.161.supplement_1.ltta-18","article-title":"Adenosine, a potent natural suppressor of arachidonic acid release and leukotriene biosynthesis in human neutrophils","volume":"161","author":"Flamand","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bcp.2022.115385_b0155","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejmech.2011.12.009","article-title":"Pyrrole alkanoic acid derivatives as nuisance inhibitors of microsomal prostaglandin E2 synthase-1","volume":"48","author":"Wiegard","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2022.115385_b0160","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bcp.2016.11.004","article-title":"Michael acceptor containing drugs are a novel class of 5-lipoxygenase inhibitor targeting the surface cysteines C416 and C418","volume":"125","author":"Maucher","year":"2017","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2022.115385_b0165","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.1096\/fj.201802509R","article-title":"Targeting biosynthetic networks of the proinflammatory and proresolving lipid metabolome","volume":"33","author":"Werner","year":"2019","journal-title":"FASEB J."},{"issue":"16","key":"10.1016\/j.bcp.2022.115385_b0170","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1007\/s00018-009-0078-3","article-title":"Hyperforin is a novel type of 5-lipoxygenase inhibitor with high efficacy in vivo","volume":"66","author":"Feisst","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"issue":"10","key":"10.1016\/j.bcp.2022.115385_b0175","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.1073\/pnas.050588997","article-title":"5-lipoxygenase is phosphorylated by p38 kinase-dependent MAPKAP kinases","volume":"97","author":"Werz","year":"2000","journal-title":"PNAS"},{"issue":"11","key":"10.1016\/j.bcp.2022.115385_b0180","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1096\/fj.01-0909fje","article-title":"Extracellular signal-regulated kinases phosphorylate 5-lipoxygenase and stimulate 5-lipoxygenase product formation in leukocytes","volume":"16","author":"Werz","year":"2002","journal-title":"FASEB J."},{"issue":"6014","key":"10.1016\/j.bcp.2022.115385_b0185","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1126\/science.1197203","article-title":"The structure of human 5-lipoxygenase","volume":"331","author":"Gilbert","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.bcp.2022.115385_b0190","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.abb.2014.01.017","article-title":"A mutation interfering with 5-lipoxygenase domain interaction leads to increased enzyme activity","volume":"545","author":"Rakonjac Ryge","year":"2014","journal-title":"Arch. Biochem. Biophys."},{"issue":"1","key":"10.1016\/j.bcp.2022.115385_b0195","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/bcpt.12114","article-title":"Recent advances in the search for novel 5-lipoxygenase inhibitors","volume":"114","author":"Steinhilber","year":"2014","journal-title":"Basic Clin. Paharmacol. Toxicol."},{"issue":"3","key":"10.1016\/j.bcp.2022.115385_b0200","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.bcp.2005.04.018","article-title":"Development of 5-lipoxygenase inhibitors\u2013lessons from cellular enzyme regulation","volume":"70","author":"Werz","year":"2005","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2022.115385_b0205","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1476-5381.2010.00930.x","article-title":"The 5-lipoxygenase inhibitor, zileuton, suppresses prostaglandin biosynthesis by inhibition of arachidonic acid release in macrophages","volume":"161","author":"Rossi","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2022.115385_b0210","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0891-5849(98)00179-8","article-title":"Modulation of arachidonic acid metabolism by phenols: relation to their structure and antioxidant\/prooxidant properties","volume":"26","author":"Alanko","year":"1999","journal-title":"Free Radic. Biol. Med."},{"issue":"34","key":"10.1016\/j.bcp.2022.115385_b0215","doi-asserted-by":"crossref","first-page":"6899","DOI":"10.1039\/C8SC02634C","article-title":"Machine intelligence decrypts beta-lapachone as an allosteric 5-lipoxygenase inhibitor","volume":"9","author":"Rodrigues","year":"2018","journal-title":"Chem. Sci."},{"issue":"7","key":"10.1016\/j.bcp.2022.115385_b0220","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/s41557-022-00964-7","article-title":"Controlled masking and targeted release of redox-cycling ortho-quinones via a C-C bond-cleaving 1,6-elimination","volume":"14","author":"Dunsmore","year":"2022","journal-title":"Nat. Chem."},{"issue":"8","key":"10.1016\/j.bcp.2022.115385_b0225","doi-asserted-by":"crossref","DOI":"10.3390\/ma14081984","article-title":"Recent Developments in Effective Antioxidants: The Structure and Antioxidant Properties","volume":"14","author":"Parcheta","year":"2021","journal-title":"Materials (Basel)"},{"key":"10.1016\/j.bcp.2022.115385_b0230","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000212741","article-title":"Dietary flavonoids as antioxidants","volume":"61","author":"Terao","year":"2009","journal-title":"Forum Nutr."},{"issue":"12","key":"10.1016\/j.bcp.2022.115385_b0235","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/j.drudis.2014.08.006","article-title":"Multi-target approach for natural products in inflammation","volume":"19","author":"Koeberle","year":"2014","journal-title":"Drug Discov. Today"},{"issue":"12","key":"10.1016\/j.bcp.2022.115385_b0240","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.bcp.2011.07.093","article-title":"Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications","volume":"82","author":"Singh","year":"2011","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2022.115385_b0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2015.06.022","article-title":"Perspective of microsomal prostaglandin E2 synthase-1 as drug target in inflammation-related disorders","volume":"98","author":"Koeberle","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2022.115385_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114825","article-title":"Natural chalcones elicit formation of specialized pro-resolving mediators and related 15-lipoxygenase products in human macrophages","volume":"195","author":"Kretzer","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2022.115385_b0255","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1084\/jem.178.4.1347","article-title":"Lipopolysaccharides prime whole human blood and isolated neutrophils for the increased synthesis of 5-lipoxygenase products by enhancing arachidonic acid availability: involvement of the CD14 antigen","volume":"178","author":"Surette","year":"1993","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.bcp.2022.115385_b0260","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0022-3565(25)38889-0","article-title":"In vivo characterization of zymosan-induced mouse peritoneal inflammation","volume":"269","author":"Rao","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295222004816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295222004816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:40:54Z","timestamp":1757770854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295222004816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":52,"alternative-id":["S0006295222004816"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2022.115385","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Highly potent and selective 5-lipoxygenase inhibition by new, simple heteroaryl-substituted catechols for treatment of inflammation","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2022.115385","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115385"}}